Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Chem ; 298(9): 102317, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35926706

RESUMO

The Na+,K+-ATPase generates electrochemical gradients of Na+ and K+ across the plasma membrane via a functional cycle that includes various phosphoenzyme intermediates. However, the structure and function of these intermediates and how metal fluorides mimick them require further investigation. Here, we describe a 4.0 Å resolution crystal structure and functional properties of the pig kidney Na+,K+-ATPase stabilized by the inhibitor beryllium fluoride (denoted E2-BeFx). E2-BeFx is expected to mimic properties of the E2P phosphoenzyme, yet with unknown characteristics of ion and ligand binding. The structure resembles the E2P form obtained by phosphorylation from inorganic phosphate (Pi) and stabilized by cardiotonic steroids, including a low-affinity Mg2+ site near ion binding site II. Our anomalous Fourier analysis of the crystals soaked in Rb+ (a K+ congener) followed by a low-resolution rigid-body refinement (6.9-7.5 Å) revealed preocclusion transitions leading to activation of the dephosphorylation reaction. We show that the Mg2+ location indicates a site of initial K+ recognition and acceptance upon binding to the outward-open E2P state after Na+ release. Furthermore, using binding and activity studies, we find that the BeFx-inhibited enzyme is also able to bind ADP/ATP and Na+. These results relate the E2-BeFx complex to a transient K+- and ADP-sensitive E∗P intermediate of the functional cycle of the Na+,K+-ATPase, prior to E2P.


Assuntos
Berílio , Glicosídeos Cardíacos , Fluoretos , Rim , ATPase Trocadora de Sódio-Potássio , Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Berílio/química , Glicosídeos Cardíacos/química , Fluoretos/química , Rim/enzimologia , Cinética , Fosfatos/metabolismo , Fosforilação , Domínios Proteicos , ATPase Trocadora de Sódio-Potássio/antagonistas & inibidores , ATPase Trocadora de Sódio-Potássio/química , Suínos
2.
FEBS J ; 280(21): 5441-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23621633

RESUMO

Cyclopiazonic acid (CPA) is a specific and potent inhibitor of the sarcoplasmic reticulum Ca(2+)-ATPase 1a (SERCA1a). Despite high sequence similarity to SERCA1a, Listeria monocytogenes Ca(2+)-ATPase 1 (LMCA1) is not inhibited by CPA. To test whether a CPA binding site could be created while maintaining the functionality of the ATPase we targeted four amino acid positions in LMCA1 for mutational studies based on a multiple sequence alignment of SERCA-like Ca(2+)-ATPases and structural analysis of the CPA site. The identification of CPA-sensitive gain-of-function mutants pinpointed key determinants of the CPA binding site. The importance of these determinants was further underscored by the characterization of the CPA sensitivity of two additional bacterial Ca(2+)-ATPases from Lactococcus lactis and Bacillus cereus. The CPA sensitivity was predicted from their sequence compared with the LMCA1 results, and this was experimentally confirmed. Interestingly, a cluster of Lactococcus bacteria applied in the production of fermented cheese display Ca(2+)-ATPases that are predictably CPA insensitive and may originate from their coexistence with CPA-producing Penicillum and Aspergillus fungi in the cheese. The differences between bacterial and mammalian binding pockets encompassing the CPA site suggest that CPA derivatives that are specific for bacteria or other pathogens can be developed.


Assuntos
ATPases Transportadoras de Cálcio/metabolismo , Inibidores Enzimáticos/farmacologia , Indóis/farmacologia , Listeria monocytogenes/efeitos dos fármacos , Proteínas Mutantes/metabolismo , Mutação/genética , ATPases Transportadoras de Cálcio do Retículo Sarcoplasmático/metabolismo , Bacillus cereus/efeitos dos fármacos , Bacillus cereus/enzimologia , Sítios de Ligação , ATPases Transportadoras de Cálcio/antagonistas & inibidores , ATPases Transportadoras de Cálcio/genética , Lactococcus lactis/efeitos dos fármacos , Lactococcus lactis/enzimologia , Listeria monocytogenes/enzimologia , Testes de Sensibilidade Microbiana , Mutagênese Sítio-Dirigida , Proteínas Mutantes/antagonistas & inibidores , Proteínas Mutantes/genética , Conformação Proteica , ATPases Transportadoras de Cálcio do Retículo Sarcoplasmático/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa